Development of autoimmune hepatitis in the setting of long-standing primary biliary cirrhosis

American Journal of Gastroenterology

Volumn 96, Issue 10, 2001, Pages 3021-3027

  Angulo, Paul ^a   El Amin, Omer ^a   Carpenter, Herschel A ^a   Lindor, Keith D ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; PREDNISONE; URSODEOXYCHOLIC ACID;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNE HEPATITIS; BILIARY CIRRHOSIS; CASE REPORT; CLINICAL FEATURE; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; PRIORITY JOURNAL; SURVIVAL;

ADULT; AUTOIMMUNE DISEASES; FEMALE; HEPATITIS; HUMANS; LIVER CIRRHOSIS, BILIARY; MIDDLE AGED;

EID: 0034800306     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)03237-3     Document Type: Article

References (26)

1. Primary biliary cirrhosis
2. Autoimmune hepatitis
3. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome
4. Hepatitis and cholestasis in a middle-age woman
5. Autoimmune cholangiopathy: Part of the spectrum of autoimmune chronich active hepatitis
6. Histopathological features in mixed types of chronic aggressive hepatitis and primary biliary cirrhosis
7. Autoimmune cholangiopathy: The result of consecutive primary biliary cirrhosis and autoimmune hepatitis?
8. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: Clinical features and response to therapy
9. Autoimmune chronic active hepatitis responsive to immunosuppressive therapy evolving into a typical primary biliary cirrhosis syndrome: A case report
10. Mitochondrial antibodies in chronic liver disease: Further characterization on the autoantigens
11. The molecular genetics of autoimmune liver disease
12. A unified concept of autoimmune hepatitis
13. The natural course and heterogeneity of autoimmune type chronic active hepatitis
14. Chronic active hepatitis: Overlap with primary biliary cirrhosis and primary sclerosing cholangitis
15. Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis
16. Meeting report: International autoimmune hepatitis group
17. Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: Effect of ursodeoxycholic acid
18. Hepatocellular and biliary expression of HLA antigens in primary biliary cirrhosis before and after ursodeoxycholic acid therapy
19. A randomized clinical trial of ursodeoxycholic acid as adjuvant treatment to prevent liver transplant rejection
20. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis
21. Prognosis of histological cirrhosis in type 1 autoimmune hepatitis
22. A pilot double blind, controlled, 1-year trial of prednisolone treatment in primary biliary cirrhosis: Hepatic improvement but greater bone loss
23. Ursodeoxycholic acid therapy in chronic active hepatitis
24. Effects of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis: A dose-response study
25. M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis: Epitopes or epiphenomena?
26. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation